Long-term prognostic and predictive factors in 107 stage II/III breast cancer patients treated with anthracycline-based neoadjuvant chemotherapy
Open Access
- 1 May 1997
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 75 (9) , 1360-1367
- https://doi.org/10.1038/bjc.1997.230
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Adjuvant treatment of node-positive breast cancer with cyclophosphamide, doxorubicin, fluorouracil, and vincristine versus cyclophosphamide, methotrexate, and fluorouracil: final report after a 16-year median follow-up duration.Journal of Clinical Oncology, 1996
- Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapyCancer, 1988
- NEOADJUVANT CHEMOTHERAPY IN THE COMBINED MODALITY APPROACH OF LOCALLY ADVANCED NONMETASTATIC BREAST-CANCER1987
- Primary chemotherapy in the treatment of inflammatory breast carcinoma: a study of 230 cases from the Institut Gustave-Roussy.Journal of Clinical Oncology, 1986
- PATHOLOGICAL ASSESSMENT OF RESPONSE TO INDUCTION CHEMOTHERAPY IN BREAST-CANCER1986
- Adjuvant chemo- and hormonal therapy in locally advanced breast cancer: a randomized clinical studyInternational Journal of Radiation Oncology*Biology*Physics, 1985
- Pathologic predictors of early local recurrence in stage I and II breast cancer treated by primary radiation therapyCancer, 1984
- Reporting results of cancer treatmentCancer, 1981
- Combined chemotherapy-radiotherapy approach in locally advanced (T3b-T4) breast cancerCancer Chemotherapy and Pharmacology, 1978
- Evaluation of survival data and two new rank order statistics arising in its consideration.1966